International Journal of Medical and Pharmaceutical Research
2022, Volume-3, Issue-1 doi: 10.5281/zenodo.8151978
Original Article
Health Benefits of Stevia Rebaudiana-A Review
Abstract

Stevia rebaudiana leaves contain diterpene glycosides, which have a sweet taste but have no calories in meals. Stevia has been used for generations as a sweetener by the local Guarani Indians of South America to counteract the bitter taste of various medications and beverages. This plant's diterpene glycosides are 100-300 times sweeter than sucrose and are now utilised as sugar substitutes in meals and beverages. They stay stable in food products under a wide variety of temperature and pH conditions throughout processing and have no shelf life constraints. When consumed, these glycosides do not cause a glycemic reaction, making them suitable for diabetics and obese people. Because of its growing diabetic and obese population, India has enormous demand potential for this natural sweetener. Stevia extracts have a high quantity of sweetening chemicals known as steviol glycosides, in addition to medicinal benefits. Along with rebaudioside B, C, D, Dulcoside, and Steviolbioside, the principal sweetening chemicals of importance are (Stevioside and rebaudioside A).

Recommended Articles
Loading Image...
Volume-3, Issue-1
Citations
740 Views
162 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved